DY2 Stock Chart & Stats
€8.53
€0.54(2.89%)
At close: 4:00 PM EST
€8.53
€0.54(2.89%)
Day’s Range― - ―
52-Week Range€8.09 - €13.79
Previous CloseN/A
Volume50.00
Average Volume (3M)85.00
Market Cap
€2.27B
Enterprise Value€4.46K
Total Cash (Recent Filing)€190.00M
Total Debt (Recent Filing)€2.33B
Price to Earnings (P/E)―
Beta0.74
Next Earnings
Aug 06, 2026EPS Estimate
0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.15
Shares Outstanding200,326,680
10 Day Avg. Volume20
30 Day Avg. Volume85
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)1.70
Price to Sales (P/S)0.62
P/FCF Ratio21.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€12.05Price Target Upside41.29% Upside
Rating ConsensusHold
Number of Analyst Covering13
EPS Forecast (FY)1.24
Revenue Forecast (FY)€3.14B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables & Installed BaseDentsply Sirona’s core consumables and installed equipment create durable, repeat revenue streams. Consumables tied to routine procedures and service contracts produce predictable demand and margin support over time, cushioning revenue during capital-equipment cycles.
Improving Cash Flow And Active DeleveragingPositive operating cash flow improvement, ongoing free cash flow generation and meaningful debt retirements strengthen financial flexibility. Sustained cash generation and continued deleveraging reduce refinancing risk and provide resources to fund restructuring and targeted growth investments.
Product Innovation And Distribution ExpansionRecent launches (AI diagnostics, dental MRI, new endodontic systems) plus added distributor agreements bolster competitive positioning in digital dentistry. New product adoption and expanded channels can lift long-term equipment attach rates and follow-on consumable and service revenue.
Bears Say
Elevated LeverageMaterial rise in leverage reduces financial flexibility and increases vulnerability to demand shocks. A much thinner equity base magnifies earnings volatility, raises interest and covenant risk, and limits capacity for M&A or capital-intensive investments until balance sheet repair progresses.
Persistent Unprofitability And Margin PressureOngoing negative margins signal structural profit conversion issues: gross margins are reasonable but operating costs, mix shifts and tariffs are eroding profitability. Sustained unprofitability pressures retained cash, weakens ROE, and delays normalization of capital allocation decisions.
Distributor Destocking & Inventory Sell-through HeadwindDealer destocking and the pending ~$30M drop-ship inventory sell-through create structural near-term revenue and margin drag. Lower dealer inventories can suppress orders for equipment and consumables, extend recovery timing, and raise execution risk for return-to-growth targets.
DENTSPLY SIRONA News
DY2 FAQ
What was DENTSPLY SIRONA’s price range in the past 12 months?
DENTSPLY SIRONA lowest stock price was €8.09 and its highest was €13.79 in the past 12 months.
What is DENTSPLY SIRONA’s market cap?
DENTSPLY SIRONA’s market cap is €2.27B.
When is DENTSPLY SIRONA’s upcoming earnings report date?
DENTSPLY SIRONA’s upcoming earnings report date is Aug 06, 2026 which is in 10 days.
How were DENTSPLY SIRONA’s earnings last quarter?
DENTSPLY SIRONA released its earnings results on May 05, 2026. The company reported €0.237 earnings per share for the quarter, missing the consensus estimate of €0.244 by -€0.007.
Is DENTSPLY SIRONA overvalued?
According to Wall Street analysts DENTSPLY SIRONA’s price is currently Undervalued.
Does DENTSPLY SIRONA pay dividends?
DENTSPLY SIRONA pays a N/A dividend of €0.136 which represents an annual dividend yield of N/A. See more information on DENTSPLY SIRONA dividends here
What is DENTSPLY SIRONA’s EPS estimate?
DENTSPLY SIRONA’s EPS estimate is 0.31.
How many shares outstanding does DENTSPLY SIRONA have?
DENTSPLY SIRONA has 200,326,680 shares outstanding.
What happened to DENTSPLY SIRONA’s price movement after its last earnings report?
DENTSPLY SIRONA reported an EPS of €0.237 in its last earnings report, missing expectations of €0.244. Following the earnings report the stock price went down -2.175%.
Which hedge fund is a major shareholder of DENTSPLY SIRONA?
Currently, no hedge funds are holding shares in DE:DY2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DENTSPLY SIRONA Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€12.05 (41.29% Upside)
€12.05 (41.29% Upside)
Blogger Sentiment
Bullish
DE:DY2 Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth €453.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-19.26%
12-Months-Change
Fundamentals
Return on Equity
4.74%
Trailing 12-Months
Asset Growth
-13.57%
Trailing 12-Months
Company Description
DENTSPLY SIRONA
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
DY2 Company Deck
DY2 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced mix of encouraging operational and financial actions alongside notable near-term challenges. Positives include improved operating cash flow, active deleveraging (≈$79–$80M debt retired), early cost savings (≈$20M OpEx reduction in Q1) and meaningful innovation launches (AI diagnostic aid with ~46% sensitivity improvement, dental MRI clearance, new endodontic tools). Management also maintained full-year guidance and highlighted distributor expansion and early commercial traction. Offsetting these are material constant-currency revenue declines (Q1 cc sales down 6.7%, down 4.5% excluding one-time items), significant margin compression (adjusted EBITDA down 430 bps; gross profit down 560 bps), softness in several key segments (OIS, EDS, IPS, CTS), tariff-related margin pressure, distributor destocking, and an expected ~$30M inventory sell-through headwind later in the year. Given the roughly balanced set of meaningful positives (cash, cost saves, innovation, distribution) and negatives (sales declines, margin pressure, macro/timing risks), the overall tone is cautiously constructive but realistic about near-term headwinds.View all DE:DY2 earnings summariesDY2 Net sales Breakdown
15.71% Equipment & Instruments
12.45% CAD/CAM
39.92% Essential Dental Solutions
6.17% Orthodontics
16.93% Implants & Prosthetics
8.83% Wellspect Healthcare
DY2 Stock 12 Month Forecast
Average Price Target
€12.05
▲(41.29% Upside)